Metabolic Peptides in Plain Language
Metabolic peptides and compounds are research tools that interact with the body's energy regulation systems — appetite signaling, fat metabolism, insulin secretion, and energy expenditure. The OSYRIS Metabolic category contains three distinct approaches:
Incretin agonists (GLP-1/2/3, Cagrilinitide) activate hormone receptors involved in appetite, insulin, and glucose regulation. The GLP series offers single, dual, and triple receptor targeting for comparative research.
Direct fat metabolism tools (AOD-9604) act on fat tissue directly — stimulating fat breakdown and inhibiting fat formation without affecting appetite or insulin.
Exercise mimetics (SLU-PP-32, MOTS-C cross-listed from Longevity) activate metabolic pathways normally triggered by exercise — AMPK or ERR signaling.
What's in the OSYRIS Metabolic Category
| Compound | Approach | Key Target |
|---|---|---|
| GLP-1 (S) | Single incretin agonist | GLP-1 receptor |
| GLP-2 (T) | Dual incretin agonist | GIP + GLP-1 receptors |
| GLP-3 (R) | Triple incretin agonist | GIP + GLP-1 + Glucagon receptors |
| Cagrilinitide | Amylin agonist | Amylin receptors (brainstem) |
| AOD-9604 | Direct lipolysis | Beta-3 adrenergic receptors |
| SLU-PP-32 | Exercise mimetic | ERR nuclear receptors |
Where to Go Next
Choose Your Next Step
Move from the beginner overview into the category guide, collection page, or broader peptide primer depending on how deep you want to go next.
Metabolic Category Guide
Explore how incretin agonists, amylin signaling, direct lipolysis, and exercise-mimetic pathways fit together.
Metabolic Collection
Browse the OSYRIS metabolic lineup, from GLP analogs to AOD-9604 and SLU-PP-32.
What Are Research Peptides?
Start with the broad primer on what peptides are, how they are studied, and why RUO context matters.
Frequently Asked Questions
Questions About What Are Metabolic Peptides?
Compounds that activate the same receptors as incretin hormones (GLP-1, GIP) — gut hormones that regulate insulin, appetite, and glucose metabolism after eating.
To enable systematic comparison of single (GLP-1 only), dual (GIP + GLP-1), and triple (GIP + GLP-1 + glucagon) receptor targeting.
A compound that activates metabolic pathways normally triggered by exercise, allowing researchers to study which exercise benefits are pathway-specific.
No. OSYRIS metabolic compounds are research-grade for laboratory use. They are not pharmaceutical products.
GLP-1 (S) and GLP-2 (T) — both backed by extensive Phase 3 clinical trials of their pharmaceutical equivalents.
Yes — they target non-overlapping pathways (appetite vs direct lipolysis vs exercise pathways).
Keep Following the Research Trail
GLP-1 vs GLP-2 vs GLP-3 — The Incretin Agonist Progression
Complete comparison of single (semaglutide), dual (tirzepatide), and triple (retatrutide) incretin agonists. Receptors, data, research applications.
GLP-3 (R) — The Triple Agonist Frontier
Retatrutide-class triple agonism research. GIP + GLP-1 + glucagon receptor activation. Phase 2 data, hepatic fat, energy expenditure. PubMed cited.
What Are Research Peptides?
What are research peptides? A plain-language introduction covering peptide biology, how they're made, categories, quality, and regulatory context.